• Zoloft, the antidepressant, and Norvasc, its big-selling hypertension drug, were the culprits in the second quarter.

    FORBES: Magazine Article

  • Ranexa was tested on top of Norvasc in patients who were already benefiting the most from that drug.

    FORBES: A Biotech's Big Comeback

  • But it is facing similar problems, as big-selling drugs like Zoloft, for depression, and Norvasc, for hypertension, lose patent protection.

    FORBES: Magazine Article

  • Recently, Pfizer lost a case related to a patent for Norvasc, shaving six months off the life of the hypertension treatment.

    FORBES: Magazine Article

  • But the patent on combining Norvasc and Caduet lasts until 2018.

    FORBES: Pfizer Wins Longer Life For Lipitor

  • The biggest controversy is whether Pfizer will spin off its established products unit, which sells generic drugs and branded medicines like Norvasc and Zoloft that have lost patent protection.

    FORBES: Why Pfizer Will Break Up

  • India's Dr. Reddy's Laboratories (nyse: RDY - news - people ) looks ready to bring a so-called branded generic version of Norvasc, Pfizer's best-selling hypertension medicine, to market.

    FORBES: Pfizer's Next Move

  • Too bad Norvasc loses patent protection next year.

    FORBES: Are Drug Patents Too Short?

  • Caduet will also provide another big benefit for patients with health insurance: Because it is a single pill, patients will get both drugs for a single co-payment, making it inexpensive for them even after Norvasc becomes a cheap generic.

    FORBES: Magazine Article

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定